Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.540
-0.080 (-3.05%)
Sep 9, 2025, 4:10 PM AEST
Australian Clinical Labs Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2017 - 2020 |
Cash & Equivalents | 21.44 | 26.14 | 19.96 | 26.37 | 35.23 | Upgrade |
Short-Term Investments | 0.68 | 0.71 | 0.63 | 1.13 | 1.05 | Upgrade |
Cash & Short-Term Investments | 22.12 | 26.85 | 20.59 | 27.51 | 36.28 | Upgrade |
Cash Growth | -17.60% | 30.40% | -25.16% | -24.19% | 2.83% | Upgrade |
Accounts Receivable | 70.33 | 75.62 | 70.26 | 87.47 | 61.52 | Upgrade |
Other Receivables | 2.47 | 5.81 | 4.69 | 3.67 | 1.46 | Upgrade |
Receivables | 72.8 | 81.43 | 74.96 | 91.14 | 62.98 | Upgrade |
Inventory | 15.62 | 16.83 | 15.09 | 20.09 | 13.36 | Upgrade |
Prepaid Expenses | 9.52 | 8.5 | 5.32 | 4.14 | 4.61 | Upgrade |
Total Current Assets | 120.07 | 133.6 | 115.96 | 142.87 | 117.23 | Upgrade |
Property, Plant & Equipment | 270.11 | 281.7 | 288.44 | 310.2 | 238.34 | Upgrade |
Goodwill | 159.11 | 158.68 | 158.68 | 158.68 | 105.98 | Upgrade |
Other Intangible Assets | 6.1 | 6.26 | 6.49 | 6.72 | 6.92 | Upgrade |
Long-Term Deferred Tax Assets | 16.97 | 10.74 | 8.23 | 9.42 | 15.63 | Upgrade |
Other Long-Term Assets | 2.48 | 2.07 | 1.11 | 0.15 | - | Upgrade |
Total Assets | 574.84 | 593.06 | 578.91 | 628.04 | 484.1 | Upgrade |
Accounts Payable | 20.54 | 26.19 | 17.97 | 26.47 | 18.57 | Upgrade |
Accrued Expenses | 45.75 | 44.62 | 43.79 | 46.33 | 42.77 | Upgrade |
Current Portion of Leases | 108.6 | 104.71 | 101.09 | 94.77 | 70 | Upgrade |
Current Income Taxes Payable | 8.54 | 3.24 | 0.01 | 5.62 | 4.02 | Upgrade |
Other Current Liabilities | 32.98 | 28.95 | 25.08 | 51.98 | 30.42 | Upgrade |
Total Current Liabilities | 216.41 | 207.7 | 187.93 | 225.16 | 165.78 | Upgrade |
Long-Term Debt | 41.97 | 55.06 | 65.7 | - | 99.51 | Upgrade |
Long-Term Leases | 139.81 | 149.13 | 149.54 | 167.61 | 134.34 | Upgrade |
Other Long-Term Liabilities | 0.98 | - | - | - | - | Upgrade |
Total Liabilities | 402.86 | 415.3 | 406.24 | 395.49 | 402.19 | Upgrade |
Common Stock | 780.73 | 797.98 | 797.98 | 797.98 | 797.98 | Upgrade |
Retained Earnings | 33.75 | 26.27 | 22.45 | 83.43 | -70.59 | Upgrade |
Treasury Stock | -5.21 | -6.21 | -5.84 | -4.94 | - | Upgrade |
Comprehensive Income & Other | -637.92 | -640.5 | -642.18 | -644.02 | -645.48 | Upgrade |
Total Common Equity | 171.35 | 177.53 | 172.42 | 232.44 | 81.9 | Upgrade |
Minority Interest | 0.63 | 0.24 | 0.25 | 0.11 | 0.02 | Upgrade |
Shareholders' Equity | 171.98 | 177.77 | 172.67 | 232.56 | 81.91 | Upgrade |
Total Liabilities & Equity | 574.84 | 593.06 | 578.91 | 628.04 | 484.1 | Upgrade |
Total Debt | 290.38 | 308.9 | 316.32 | 262.38 | 303.85 | Upgrade |
Net Cash (Debt) | -268.26 | -282.05 | -295.73 | -234.87 | -267.57 | Upgrade |
Net Cash Per Share | -1.41 | -1.41 | -1.47 | -1.17 | -1.76 | Upgrade |
Filing Date Shares Outstanding | 194.47 | 200.24 | 200.5 | 200.81 | 201.83 | Upgrade |
Total Common Shares Outstanding | 194.47 | 200.24 | 200.5 | 200.81 | 201.83 | Upgrade |
Working Capital | -96.34 | -74.1 | -71.97 | -82.29 | -48.55 | Upgrade |
Book Value Per Share | 0.88 | 0.89 | 0.86 | 1.16 | 0.41 | Upgrade |
Tangible Book Value | 6.15 | 12.58 | 7.25 | 67.04 | -31.01 | Upgrade |
Tangible Book Value Per Share | 0.03 | 0.06 | 0.04 | 0.33 | -0.15 | Upgrade |
Machinery | 120.06 | 115.36 | 111.74 | 106.27 | 87.76 | Upgrade |
Construction In Progress | 0.7 | 0.21 | 1.69 | 3.35 | 1.69 | Upgrade |
Leasehold Improvements | 57.86 | 56.12 | 53.96 | 51.73 | 44.97 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.